The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma
Official Title: A Phase III Randomized Study Evaluating Gemcitabine and Paclitaxel Versus Gemcitabine Alone After FOLFIRINOX Failure or Intolerance in Metastatic Pancreatic Ductal Adenocarcinoma
Study ID: NCT03943667
Brief Summary: This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ductal Adenocarcinoma (PDAC) after FOLFIRINOX failure or intolerance.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
CH de Bayeux, Bayeux, , France
CH Simone Veil, Beauvais, , France
CHU Jean Minjoz, Besançon, , France
Hôpital Duchenne, Boulogne-sur-Mer, , France
CH du Cotentin, Cherbourg, , France
Centre Georges François Leclerc, Dijon, , France
Centre Léon Bérard, Lyon, , France
Hospices civils de Lyon, Lyon, , France
CHU La Timone, Marseille, , France
Hôpital Européen de Marseille, Marseille, , France
Hôpital Saint-Joseph, Marseille, , France
Institut Paoli Calmettes, Marseille, , France
Hôpital Nord Franche Comté, Montbéliard, , France
Centre Antoine Lacassagne, Nice, , France
Hôpital Saint-Louis, Paris, , France
Institut Mutualiste Montsouris, Paris, , France
Hôpital Pitié-Salpétrière, Paris, , France
Institut Godinot, Reims, , France
Centre Eugène Marquis, Rennes, , France
CHU Rouen, Rouen, , France
Institut Curie, Saint-Cloud, , France
Institut de Cancérologie de l'Ouest, Saint-Herblain, , France
Hôpital Broussais, Saint-Malo, , France
CHU de Saint-Etienne, Saint-Étienne, , France
Hôpital Trousseau, Tours, , France
Institut Gustave Roussy, Villejuif, , France
Name: Christelle de la FOUCHARDIERE, Dr
Affiliation: UNICANCER
Role: PRINCIPAL_INVESTIGATOR